DKSH has acquired the ear care brands Audisol and Audiplugs from Noru Pharma to enhance its Healthcare Own Brands business across Australia, New Zealand, and select Asian markets.
Information on the Target
DKSH has finalized an agreement to acquire two ear care brands, Audisol and Audiplugs, from Noru Pharma. This acquisition specifically targets the markets in Australia, New Zealand, and select areas in Asia. Audisol specializes in products that cater to everyday needs in ear treatment, while Audiplugs offers a comprehensive selection of high-quality earplugs. Both brands currently operate in Australia, New Zealand, and Singapore, with plans from DKSH to gradually extend their presence into additional markets.
The portfolio acquired is expected to significantly enhance DKSH's Healthcare Own Brands division, bringing the total number of markets served in the Asia Pacific region to 14. The acquisition includes a diverse range of products that not only meet consumer needs but also align with DKSH's commitment to providing high-quality healthcare solutions.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The ear care segment within the healthcare industry has shown resilience and potential for growth, particularly in Australia and New Zealand. The increasing awareness about ear health, coupled with the rising incidence of hearing impairments, ha
Similar Deals
DKSH
invested in
Noru Pharma's ear care brands (Audisol and Audiplugs)
in 2022
in a Other deal
Disclosed details
Revenue: $2M